SVF (Stromal Vascular Fraction) therapy has become one of the most discussed regenerative treatment approaches for patients seeking joint-preserving options for Hip Avascular Necrosis (AVN) and Knee Osteoarthritis.
By utilizing cells obtained from a patient's own adipose (fat) tissue, SVF therapy is being used in selected patients as part of modern regenerative orthopedic care aimed at supporting mobility, function, and quality of life.